Market Research Logo

US Market Overview for Robotic Assisted Surgery Systems 2017 - MedView

EXECUTIVE SUMMARY
U.S. SURGICAL NAVIGATION AND ROBOTIC SYSTEMS MARKET
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
MARKETS INCLUDED
PROCEDURES
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 MEDICAL CONDITIONS
2.1.1 Neurosurgery Conditions
2.1.1.1 Hydrocephalus
2.1.1.2 Communicating Hydrocephalus
2.1.1.3 Normal Pressure Hydrocephalus
2.1.1.4 Non-Communicating Hydrocephalus
2.1.1.5 Brain Tumor
2.1.1.6 Intracranial Pressure
2.1.1.7 Intracranial Aneurysm
2.1.1.8 Intracranial Atherosclerosis Disease
2.1.2 Spinal Conditions
2.1.2.1 Herniated Disc
2.1.2.2 Spinal Stenosis
2.1.2.3 Spondylosis
2.1.2.4 Scoliosis
2.1.2.5 Lordosis
2.1.2.6 Kyphosis
2.1.3 ENT Conditions
2.1.3.1 Otitis Media
2.1.3.2 Cholesteatomas
2.1.3.3 Otosclerosis
2.1.3.4 Chronic Sinusitis
2.1.3.5 Tonsillitis
2.1.4 Orthopedic Conditions
2.1.4.1 Fractures
2.1.4.2 Osteoporosis
2.1.4.3 Arthritis
2.1.5 Gynecological Conditions
2.1.5.1 Gynecological Cancers
2.1.5.2 Uterine Fibroids
2.1.5.3 Endometriosis
2.1.5.4 Menorrhagia
2.1.5.5 Pelvic Prolapse
2.1.6 Urological Conditions
2.1.6.1 Prostate Cancer
2.1.6.2 Bladder Cancer
2.1.6.3 Kidney Cancer
2.1.6.4 Benign Prostate Hyperplasia (BPH)
2.1.7 Digestive Tract Conditions
2.1.7.1 Achalasia
2.1.7.2 Stomach Cancer
2.1.7.3 Hernia
2.1.7.4 Gallbladder Attack
2.1.7.5 Gastroesophageal Reflex Disease
2.1.8 Colorectal Conditions
2.1.8.1 Colorectal Cancer
2.1.8.2 Inflammatory Bowel Disease
2.1.8.3 Diverticulitis
2.1.9 Cardiac Conditions
2.1.9.1 Mitral Valve Prolapse
2.1.9.2 Coronary Artery Disease
PRODUCT ASSESSMENT
3.1 ROBOTIC ASSISTED SURGERY PRODUCT PORTFOLIOS
3.1.1 Robotic-Assisted Surgery Overview
3.1.2 Neurosurgery
3.1.3 Spine Surgery
3.1.4 Orthopedic Surgery
3.1.5 Minimally Invasive Surgery
3.1.6 Radiosurgery
3.1.7 Catheter Placement
3.2 RAS REGULATORY ISSUES AND RECALLS
3.2.1 Accuray Inc.
3.2.2 Blue Belt Technologies
3.2.3 Hansen Medical Inc.
3.2.4 Intuitive Surgical
3.2.5 MAKO Surgical/Stryker
3.2.6 OMNIlife Science
3.3 CLINICAL TRIALS
3.4 RAS CLINICAL TRIALS
3.4.1 Accuray Inc.
3.4.2 Catheter Precision
3.4.3 Corindus Inc
3.4.4 Hansen Medical
3.4.5 Intuitive Surgical
3.4.6 MAKO Surgical/Stryker
3.4.7 Mazor
3.4.8 Medrobotics
3.4.9 Medtech
U.S. ROBOTIC ASSISTED SURGERY SYSTEM MARKET
4.1 INTRODUCTION
4.1.1 Surgical Robotic System Market and Segmentation
4.2 MARKET OVERVIEW: SYSTEM SALES AND TOTAL REVENUE
4.3 MARKET OVERVIEW BY SEGMENT
4.4 TREND ANALYSIS
4.5 DRIVERS AND LIMITERS
4.5.1 Market Drivers
4.5.2 Market Limiters
4.6 COMPETITIVE ANALYSIS
4.7 COMPANY PROFILES
4.7.1 Accuray Inc
4.7.2 Blue Belt Technologies/Smith & Nephew
4.7.3 Catheter Precision
4.7.4 Corindus Vascular Robotics
4.7.5 Hansen Medical
4.7.6 Intuitive Surgical
4.7.7 Stryker/Mako
4.7.8 Medtech
4.7.9 Mazor Robotics
4.7.10 Medrobotics
4.7.11 OMNI
4.7.12 Renishaw
4.7.13 THINK Surgical (Formerly known as Curexo Technologies)
4.8 MERGERS AND ACQUISITIONS
ABBREVIATIONS
List of Charts
Chart 1 1: Surgical Navigation Systems Market by Segment, U.S, 2013 – 2023
Chart 1 2: Surgical Robotics Systems Market by Segment, U.S, 2013 – 2023
Chart 1 3: Robotics and Surgical Navigation Systems Market Overview, U.S., 2013 & 2023
Chart 4 1: System Sales Revenue and Total Market Revenue, Total Robotic Assisted Surgery System Market, U.S., 2013 – 2023
Chart 4 2: Robotic Assisted Surgery System Market by Segment, U.S., 2013 – 2023
Chart 4 3: Robotic Assisted Surgery System Market Breakdown, U.S., 2016
Chart 4 4: Robotic Assisted Surgery System Market Breakdown, U.S., 2023
Chart 4 5: Growth Rates by Segment, Robotic Assisted Surgery System Market, U.S., 2013 – 2023
Chart 4 6: Leading Competitors, Robotic Assisted Surgery System Market, U.S., 2016
List of Figures
Figure 1 1: Surgical Navigation Systems Competitor Market Share Ranking by Segment, U.S., 2016
Figure 1 2: Surgical Robotics Competitor Market Share Ranking by Segment, U.S., 2016 (2 of 2)
Figure 1 3: Companies Researched in this Report, U.S., 2016
Figure 1 4: Factors Impacting the Robotics and Surgical Navigation Systems Market by Segment, U.S., 2016 (1 of 3)
Figure 1 5: Factors Impacting the Robotics and Surgical Navigation Systems Market by Segment, U.S., 2016 (2 of 3)
Figure 1 6: Factors Impacting the Robotics and Surgical Navigation Systems Market by Segment, U.S., 2016 (3 of 3)
Figure 1 7: Recent Events in the Robotics and Surgical Navigation Systems, Europe, 2013 – 2016
Figure 1 8: Robotics and Surgical Navigation Systems Markets Covered, U.S., 2016
Figure 1 9: Robotics and Surgical Navigation Systems Procedures Covered, U.S., 2016 (1 of 2)
Figure 1 10: Robotics and Surgical Navigation Systems Procedures Covered, U.S., 2016 (2 of 2)
Figure 1 11: Key Report Updates
Figure 1 12: Version History
Figure 3 1: Robot-Assisted Neurosurgery Products by Company
Figure 3 2: Robot-Assisted Spine Surgery Products by Company
Figure 3 3: Robot-Assisted Orthopedic Surgery Products by Company
Figure 3 4: Robot-Assisted Radiosurgery Products by Company
Figure 3 5: Robot-Assisted Catheter Placement Products by Company
Figure 3 6: Class 2 Device Recall Accuray Inc
Figure 3 7: Class 2 Device Recall Accuray Inc
Figure 3 8: Class 2 Device Recall Accuray Inc
Figure 3 9: Class 2 Device Recall Accuray Inc
Figure 3 10: Class 2 Device Recall Accuray Inc
Figure 3 11: Class 2 Device Recall Accuray Inc
Figure 3 12: Class 2 Device Recall Blue Belt Technologies
Figure 3 13: Class 2 Device Recall Blue Belt Technologies
Figure 3 14: Class 2 Device Recall Blue Belt Technologies
Figure 3 15: Class 2 Device Recall Hansen Medical
Figure 3 16: Class 2 Device Recall Hansen Medical
Figure 3 17: Class 2 Device Recall Hansen Medical
Figure 3 18: Class 2 Device Recall Intuitive Surgical
Figure 3 19: Class 2 Device Recall Intuitive Surgical
Figure 3 20: Class 2 Device Recall Intuitive Surgical
Figure 3 21: Class 2 Device Recall Intuitive Surgical
Figure 3 22: Class 2 Device Recall Intuitive Surgical
Figure 3 23: Class 2 Device Recall Intuitive Surgical
Figure 3 24: Class 2 Device Recall Intuitive Surgical
Figure 3 25: Class 2 Device Recall Intuitive Surgical
Figure 3 26: Class 2 Device Recall Intuitive Surgical
Figure 3 27: Class 2 Device Recall Intuitive Surgical
Figure 3 28: Class 2 Device Recall Intuitive Surgical
Figure 3 29: Class 2 Device Recall Intuitive Surgical
Figure 3 30: Class 2 Device Recall Intuitive Surgical
Figure 3 31: Class 2 Device Recall Intuitive Surgical
Figure 3 32: Class 2 Device Recall Intuitive Surgical
Figure 3 33: Class 2 Device Recall Intuitive Surgical
Figure 3 34: Class 2 Device Recall Intuitive Surgical
Figure 3 35: Class 2 Device Recall Intuitive Surgical
Figure 3 36: Class 2 Device Recall Intuitive Surgical
Figure 3 37: Class 2 Device Recall Intuitive Surgical
Figure 3 38: Class 2 Device Recall Intuitive Surgical
Figure 3 39: Class 2 Device Recall Intuitive Surgical
Figure 3 40: Class 2 Device Recall Intuitive Surgical
Figure 3 41: Class 2 Device Recall Intuitive Surgical
Figure 3 42: Class 2 Device Recall Intuitive Surgical
Figure 3 43: Class 2 Device Recall Intuitive Surgical
Figure 3 44: Class 2 Device Recall Intuitive Surgical
Figure 3 45: Class 2 Device Recall Intuitive Surgical
Figure 3 46: Class 2 Device Recall Intuitive Surgical
Figure 3 47: Class 2 Device Recall Intuitive Surgical
Figure 3 48: Class 2 Device Recall Intuitive Surgical
Figure 3 49: Class 2 Device Recall Intuitive Surgical
Figure 3 50: Class 2 Device Recall Intuitive Surgical
Figure 3 51: Class 2 Device Recall Intuitive Surgical
Figure 3 52: Class 2 Device Recall Intuitive Surgical
Figure 3 53: Class 2 Device Recall Intuitive Surgical
Figure 3 54: Class 2 Device Recall Intuitive Surgical
Figure 3 55: Class 2 Device Recall Intuitive Surgical
Figure 3 56: Class 2 Device Recall Intuitive Surgical
Figure 3 57: Class 2 Device Recall Intuitive Surgical
Figure 3 58: Class 2 Device Recall Intuitive Surgical
Figure 3 59: Class 2 Device Recall Intuitive Surgical
Figure 3 60: Class 2 Device Recall Intuitive Surgical
Figure 3 61: Class 2 Device Recall Intuitive Surgical
Figure 3 62: Class 2 Device Recall Intuitive Surgical
Figure 3 63: Class 2 Device Recall MAKO Surgical/Stryker
Figure 3 64: Class 2 Device Recall MAKO Surgical/Stryker
Figure 3 65: Class 2 Device Recall MAKO Surgical/Stryker
Figure 3 66: Class 2 Device Recall MAKO Surgical/Stryker
Figure 3 67: Class 2 Device Recall MAKO Surgical/Stryker
Figure 3 68: Class 2 Device Recall MAKO Surgical/Stryker
Figure 3 69: Class 2 Device Recall OMNIlife Science, Inc
Figure 3 70: Class 2 Device Recall OMNIlife Science, Inc
Figure 3 71: Class 2 Device Recall OMNIlife Science, Inc
Figure 3 72: Class 2 Device Recall OMNIlife Science, Inc
Figure 3 73: Class 2 Device Recall OMNIlife Science, Inc
Figure 3 74: Endoscopic Evaluation of Late Rectal Injury Following CyberKnife Radiosurgery for Prostate Cancer
Figure 3 75: CyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate Cancer
Figure 3 76: A Phase II Trial of CyberKnife Stereotactic Radiosurgery to Prostate Tumors
Figure 3 77: Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients
Figure 3 78: A Phase II Trial of CyberKnife Radiosurgery to Perioptic Tumors
Figure 3 79: Evaluation of CyberKnife Stereotactic Radiotherapy in Prostate Cancer
Figure 3 80: An Effectiveness and Toxicity of CyberKnife Based Radiosurgery for Parkinson Disease
Figure 3 81: CyberKnife Stereotactic Accelerated Partial Breast Irradiation (SAPBI) (CK-SAPBI)
Figure 3 82: Safety and Efficacy Study of Five-fraction Stereotactic Body Radiation Therapy
Figure 3 83: A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer
Figure 3 84: Stereotactic Radiosurgery for Soft Tissue Sarcoma
Figure 3 85: A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
Figure 3 86: Safety and Feasibility of Arrhythmia Ablation Using the Amigo Remote Robotic System
Figure 3 87: Evaluation of the Amigo Robotic System for Ablation of the Cavo-Tricuspid Isthmus
Figure 3 88: Manual vs Amigo SmartTouch Atrial Fibrillation Study (MAST-AF)
Figure 3 89: Robotic-Assisted Peripheral Intervention for Peripheral Arterial Disease (RAPID)
Figure 3 90: Robotic-Assisted Peripheral Intervention for Peripheral Arterial Disease II (RAPID II)
Figure 3 91: Post-Market CorPath Registry on the CorPath 200 System
Figure 3 92: Embolization Procedures in the Peripheral Vasculature Using the Magellan™ Robotic System
Figure 3 93: Registry of the Magellan Robotic System (ROVER)
Figure 3 94: Evaluation of Clinical Outcomes in Robotic-Assisted Inguinal Hernia Repair
Figure 3 95: A Retrospective Multicenter Investigation of the Use of the da Vinci® Surgical System
Figure 3 96: Cosmesis, Patient Satisfaction and Quality of Life After da Vinci
Figure 3 97: Robotic-assisted Versus Laparoscopic Sigmoid Resection
Figure 3 98: Prospective Investigation of Robotic Single-port System
Figure 3 99: Clinical Outcomes of Knee Replacement
Figure 3 100: A Trial Evaluating TKR Compared to BKR Performed Using Stryker's Mako Robot
Figure 3 101: Robotic Arm Assisted Total Knee Arthroplasty
Figure 3 102: Outcomes of Robotic Total Hip Arthroplasty
Figure 3 103: Clinical and Economic Comparison of Robot Assisted Versus Manual Knee Replacement
Figure 3 104: Prospective, Observational Registry of Renaissance-guided Spine Surgeries
Figure 3 105: Clinical Trial of Minimally Invasive Robotic Spine Surgery
Figure 3 106: Robotic vs. Freehand Corrective Surgery for Pediatric Scoliosis (PEDSCOLI)
Figure 3 107: ADDRESS - Adult Deformity Robotic vs. Freehand Surgery to Correct Spinal Deformity
Figure 3 108: MIS ReFRESH: Robotic vs. Freehand Minimally Invasive Spinal Surgeries
Figure 3 109: A Post-Market Clinical Trial for Access and Visualization
Figure 3 110: Robotic-assisted Pedicule Screw Placement (ARASS)
Figure 4 1: System Sales Revenue and Total Market Revenue, Total Robotic Surgical System Market, U.S., 2013 – 2023
Figure 4 2: Robotic Assisted Surgery System Market by Segment, U.S., 2013 – 2023 (US$M)
Figure 4 3: Growth Rates by Segment, Robotic Assisted Surgery System Market, U.S., 2013 – 2023
Figure 4 4: Drivers and Limiters, Robotic Assisted Surgery System Market, U.S., 2016
Figure 4 5: Leading Competitors, Robotic Assisted Surgery System Market, U.S., 2016

US Market Overview for Robotic Assisted Surgery Systems 2017 - MedView

The total market value includes spinal, neurosurgery, MIS (minimally invasive surgery), radiosurgery, catheter and orthopedic robotic assisted systems. The market is currently dominated by Intuitive Surgical, but has seen strong growth on the part of smaller companies such as Medtech and Mazor Robotics. In addition to the release of several new systems, the market has also seen acquisitions of robotics companies by larger, more established implant firms with whom previous partnerships existed. This has contributed to strong overall growth. The market is expected to increase considerably over the forecast period as system sales increase in other markets than MIS, and revenue from procedures, maintenance and services increases as a result of the larger installed base. Orthopedic robotic systems, comprising the robotic assisted orthopedic surgery market, have been around since 1982 with the release of the ROBODOC®. More recently, the use of tactile and passive robotic systems for orthopedic procedures, specifically partial knee arthroplasty (PKA, also called unicompartmental knee reconstruction), have become more common. These robotic systems have addressed the usual problems that arise from performing conventional PKA. Additionally, some of these systems have software for total hip arthroplasty. Currently, this market is composed mainly of one system. But, over the forecast period, the entrance of new competitors will result in further unit sales growth and growth of the overall market. In addition, both existing and new competitors are looking at total knee arthroplasty (TKA) procedures as an avenue for significant expansion and growth, with two companies intending to market this application in 2017.

Surgery has progressed from a risky art into a sophisticated and ever-evolving scientific discipline capable of treating many diseases and conditions. Until the industrial revolution, surgeons struggled with three principal obstacles which plagued the medical profession from its infancy: bleeding, pain and infection. Recent technological advances have increased the types of procedures that are able to be performed and, more importantly, revolutionized the way in which these procedures can be performed.


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;